Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall discussions reflect high enthusiasm and interest, with phrases like 'breakthrough' and 'game changer' illustrating excitement about the potential of TNIK inhibition for aging therapy. Posts mention the integration of AI and robotics as innovative, and some highlight the significance for future pharmaceutical advancements, demonstrating recognition of substantial scientific and societal impact.
Most discussions express support or optimism about the significance of the research, with many highlighting its potential for age-related disease treatment and longevity.
Posts show high curiosity, referencing specific aspects like the AI-driven approach, the compound ISM001-055, and the implications for aging and pharmacology.
Several discussions delve into the tools and methods used, such as AI and robotic laboratories, although some comments remain more general or enthusiastic without deep technical analysis.
Many posts emphasize the transformative potential of the findings, suggesting they could revolutionize aging treatment, which indicates the perceived high impact of this research.
Big new paper alert – "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent". I’m excited to share a breakthrough that underscores the future of pharma innovation. By leveraging cutting-edge AI, advanced aging clocks, and our https://t.co/CN5VJec795
From https://t.co/4S8Lj1Qecd: How a Drug Candidate for Rare Diseases Could Be the Key to Living Longer Check out our latest paper: "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent." https://t.co/MZXUCEtR2Z
AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent
Researchers from @InSilicoMeds and two partner institutions published a study concluding that its lead candidate ISM001-055 could function as a senomorphic agent. #aging https://t.co/LLvhIUTkcV https://t.co/nFmz1RgNUO
https://t.co/GgKp0MZS2X
Link to the paper exploring rentosertib as a senomorphic agent: https://t.co/GgKp0N0pSv
The study explores the role of the kinase TNIK in aging and cellular senescence, showing that inhibiting TNIK with the compound INS018055 can decrease senescent cell accumulation and reduce proinflammatory secretions…
RT @TimePieChina: Researchers from @InSilicoMeds and two partner institutions published a study concluding that its lead candidate ISM001-0…
RT @biogerontology: Link to the paper exploring rentosertib as a senomorphic agent: https://t.co/GgKp0N0pSv
Link to the paper exploring rentosertib as a senomorphic agent: https://t.co/GgKp0N0pSv
https://t.co/GgKp0MZS2X
RT @biogerontology: https://t.co/GgKp0MZS2X
RT @biogerontology: https://t.co/GgKp0MZS2X
RT @biogerontology: https://t.co/GgKp0MZS2X
https://t.co/GgKp0MZS2X
RT @InSilicoMeds: From https://t.co/4S8Lj1Qecd: How a Drug Candidate for Rare Diseases Could Be the Key to Living Longer Check out our lat…
RT @InSilicoMeds: For more information, please visit: https://t.co/4Lsn4D3d2M
RT @InSilicoMeds: From https://t.co/4S8Lj1Qecd: How a Drug Candidate for Rare Diseases Could Be the Key to Living Longer Check out our lat…
For more information, please visit: https://t.co/4Lsn4D3d2M
From https://t.co/4S8Lj1Qecd: How a Drug Candidate for Rare Diseases Could Be the Key to Living Longer Check out our latest paper: "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent." https://t.co/MZXUCEtR2Z
RT @biogerontology: Big new paper alert – "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic…
RT @agingdoc1: AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent
AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent
RT @biogerontology: https://t.co/GgKp0MZS2X
RT @TimePieChina: Researchers from @InSilicoMeds and two partner institutions published a study concluding that its lead candidate ISM001-0…
Researchers from @InSilicoMeds and two partner institutions published a study concluding that its lead candidate ISM001-055 could function as a senomorphic agent. #aging https://t.co/LLvhIUTkcV https://t.co/nFmz1RgNUO
https://t.co/GgKp0MZS2X
https://t.co/GgKp0N0pSv
RT @biogerontology: Big new paper alert – "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic…
RT @biogerontology: https://t.co/GgKp0MZS2X
RT @biogerontology: Big new paper alert – "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic…
RT @biogerontology: Big new paper alert – "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic…
RT @biogerontology: Big new paper alert – "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic…
RT @biogerontology: Big new paper alert – "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic…
https://t.co/GgKp0MZS2X
Big new paper alert – "AI-driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent". I’m excited to share a breakthrough that underscores the future of pharma innovation. By leveraging cutting-edge AI, advanced aging clocks, and our https://t.co/CN5VJec795